RARE: Utang marang Ekuitas ultragenyx.com

RARE (Ultragenyx Corp) - tandha merek perusahaan

The market price chart on GURU.Markets shows the debt-to-equity ratio for Ultragenyx Pharmaceutical (RARE) at 0.00, while the company strictly adheres to biomedical standards for material handling. The firm generates revenue from the global sale of agents for the correction of metabolic disorders. High barriers to entry are established by patents and research investments, and business development is governed by stringent FDA oversight.

RARE: Total Utang marang Modal Ultragenyx Pharmaceutical Inc. 04.07.2022 - 01.11.2026

Rincian metrik komprehensif lan analitis Ultragenyx Corp (RARE)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Ultragenyx|RARE - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Nilai pasar Ultragenyx|RARE - Nilai Bisnis
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Ultragenyx|RARE - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih ultragenyx.com|RARE - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Ultragenyx Pharmaceutical|RARE - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Ultragenyx Pharmaceutical|RARE - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Ultragenyx|RARE - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ultragenyx|Rasio cepet ultragenyx.com
- informasi bathi lan kelipatan valuasi:
RARE - Bathi resik taunan
Pambiji fundamental:RARE, Ultragenyx
Barang utama ultragenyx.com

For Ultragenyx Pharmaceutical (RARE), which utilizes drug development outsourcing to optimize costs, this metric serves as a tool for monitoring financial stability. By analyzing the degree of equity leverage, an investor assesses the proportion of borrowed funds to shareholder resources, where a reduction in leverage confirms balance sheet reliability but may signal a slowdown in investment expansion into R&D projects.

Analisis pesaing Ultragenyx Pharmaceutical

TEM (tempus.com) - Total Utang marang Modal|Rasio Utang marang Ekuitas QGEN (Qiagen NV)|Utang marang Ekuitas Ionis Pharma (IONS)|Repligen Inc. - Rasio Utang marang Ekuitas|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|WGS: Rasio Total Utang marang Ekuitas|BEAM - Total Utang marang Modal|Sarepta Therapeutics Inc (SRPT) - Utang marang Ekuitas|TWST (Twist Bioscience Corp) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas TXG|NTLA (intelliatx.com) - Utang Agregat marang Modal|Utang marang Ekuitas Stoke Therapeutics, Inc. (STOK)|BLFS (BioLife Solutions Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal WVE (Wave Life Sciences Corp)|Total Utang marang Modal Maze Therapeutics Corp MAZE|Sionna Therapeutics Inc - Total Utang marang Modal|Rasio Utang marang Modal primemedicine.com (PRME)|TSHA: Total Utang marang Modal|Utang marang Modal uniQure NV (QURE)|Utang marang Ekuitas MeiraGTx PLC|Rasio Utang marang Ekuitas RGNX (REGENXBIO Corp)|Rasio Total Utang marang Ekuitas SLDB (Solid Biosciences Inc.)|OCGN - Utang marang Modal|PacBio - Rasio Total Utang marang Ekuitas|BNTC: Rasio Utang marang Ekuitas|DSGN: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi RCKT (Rocket Corp)|4D Molecular Therapeutics (FDMT) - Utang marang Ekuitas|Utang Agregat marang Ekuitas LXEO (Lexeo Therapeutics, Inc.)|KRRO (Korro Bio Inc.) - Total Utang marang Modal|EDIT: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SLN|Total Utang marang Modal proqr.com (PRQR)|Utang marang Ekuitas Codexis CDXS|Rasio Kabeh Utang marang Dana Pribadi SGMO|NAUT - Utang marang Ekuitas|Metagenomi Inc. (MGX) - Rasio Total Utang marang Ekuitas|DTIL: Total Utang marang Modal|Generation Bio (GBIO) - Total Utang marang Modal|BOLD (Boundless Bio, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Exicure Corp (XCUR)|Total Utang marang Modal IMNN|PHIO - Utang marang Modal|Mustang Bio - Rasio Total Utang marang Ekuitas|Total Utang marang Modal TransCode Therapeutics Inc. RNAZ|BNGO: Rasio Total Utang marang Ekuitas|adnas.com - Utang Agregat marang Modal|BLUE: Total Utang marang Modal|IPA - Koefisien Total Utang marang Modal|OMGA (Omega) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Singular Genomics Corp (OMIC)|Total Utang marang Modal RGLS|Total Utang marang Modal syros.com (SYRS)|Utang marang Ekuitas Telesis Bio TBIO|TRACON Pharmaceuticals Inc. - Utang marang Ekuitas|UBX - Utang marang Ekuitas